Biomarin Pharmaceutical Aktie
58,14
EUR
-0,04
EUR
-0,07
%
61,71
USD
-0,21
USD
-0,34
%
Biomarin Pharmaceutical Aktie Analyse
19.07.05 | Biomarin Pharmaceutical | Global Biotech Investing | |
12.05.05 | Biomarin Pharmaceutical Market Outperform | Rodman & Renshaw |